Theratechnologies Inc T.TH

Getting a Green Light rather than a Yellow Light from FDA

[palinc2000]

is a pre requisite IMO before management can go all out on attracting Institutions and major players

[SPCEO1]

I think it would be closer to the truth to say the light is just a lighter green, not yellow. The FDA has approved a phase III NASH trial and just has some additional guidnace they want to give. At least that is the impression management has left with the way they have described it.

[qwerty22]

The fact there is room to argue the colour of the light is the issue. 

[palinc2000]

Fda requesting a Meeting to discuss questions and commentson certain aspects of the proposed trial design  is not a Green Light ,,,,,at most it would be a Flashing Yellow Light

[Wino115]

It would not surprise me that the 3 large anchor investors know a bit more because they would have been able to get all the top guys on one call and dig much more than we can. I can tell you that I never would become an anchor, stuck in a microcap, without having all my questions answered by management. Obviously with the regulations around news, it couldn't be something "material"

[scarlet1967]

My take is progressively every time  they address the NASH trial they sound more confident for instance in the previous CC the CEO was stating they know the drug is working and want to get the chance to proove it, the PR states they got the formal positive response from FDA with the recommendation to discus the trial's design and yesterday he hinted it is fine details which needs to be

[palinc2000]

I am 80% there but the market is not even cloise to that ,,,,maybe even lower than 15-20% Going from such low confidence to 100% will be a market mover

[SPCEO1]

If it is true the three new institutional investors did acquire 60% of the deal, then that means they put up a little less than $10 million on average, which is not a huge committment for a large fund. Still, it is not tiny either, so perhaps the best takeaway from the financing is three competent analysts/portfolio managers see the same things we see and were able to recognize that TH was willing

[JayjayUSA12007]

Well, I have been a THERA shareholders for more than 10 yrs. This time, I lost confidence in its BOD and management. I will vote, if having an opportunity, to reject the entire BOD, for selling out shareholders down the river. Now, let's see whether this BOD will grant themseves cheap options based on the current price.